Editorial

Heart Failure Reviews

Volumn 6, Issue 4, 2001, Pages 249-251

  Clozel, Martine ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR;

ANIMAL; CLINICAL TRIAL; DRUG TARGETING; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; LONG TERM CARE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ENDOTHELIN-1; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; RECEPTORS, ENDOTHELIN;

EID: 0035656040     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011460318319     Document Type: Editorial

References (11)

1. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
2. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
3. Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolermia in vitro
4. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
5. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
6. A antagonist EMD94246 in rats with experimental myocardial infarction
7. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
8. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
9. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
10. LU135252, an endothelin A receptor antagonist did not prevent pulmonary vascular remodeling or lung fibrosis in a rat model of myocardial infarction
11. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension